Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

Synergy Pharmaceuticals, Inc.

New York, New York

 

We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our reports dated March 1, 2017, relating to the consolidated financial statements and the effectiveness of Synergy Pharmaceuticals, Inc.’s internal control over financial reporting, appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. Our report on the financial statements contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

 

 

/s/ BDO USA, LLP

 

New York, New York

 

 

 

August 17, 2017